Why the study?
Does the implementation of the National Service Framework improve the prevalence of secondary prevention medication use in older British men with CHD?
Does the implementation of the National Service Framework improve the prevalence of secondary prevention medication use in older British men with CHD?
Despite the introduction of the National Service Framework, significant age-related inequalities persist in the use of secondary prevention medications, particularly statins, among older men with CHD.
No takes yet. Share an insight, caveat, or question.
Persistent age disparities in statin use post-NSF; leaves open whether targeted strategies can reduce inequalities in older men with CHD.
Ramsay et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: